HIV, HSV, SARS-CoV-2 and Ebola Share Long-Term Neuropsychiatric Sequelae
Status PubMed-not-MEDLINE Jazyk angličtina Země Nový Zéland Médium electronic-ecollection
Typ dokumentu časopisecké články, přehledy
PubMed
36221293
PubMed Central
PMC9548297
DOI
10.2147/ndt.s382308
PII: 382308
Knihovny.cz E-zdroje
- Klíčová slova
- HIV-1, SARS virus, interoception, neuropsychiatry, virus latency,
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Long COVID, in which disease-related symptoms persist for months after recovery, has led to a revival of the discussion of whether neuropsychiatric long-term symptoms after viral infections indeed result from virulent activity or are purely psychological phenomena. In this review, we demonstrate that, despite showing differences in structure and targeting, many viruses have highly similar neuropsychiatric effects on the host. Herein, we compare severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), human immunodeficiency virus 1 (HIV-1), Ebola virus disease (EVD), and herpes simplex virus 1 (HSV-1). We provide evidence that the mutual symptoms of acute and long-term anxiety, depression and post-traumatic stress among these viral infections are likely to result from primary viral activity, thus suggesting that these viruses share neuroinvasive strategies in common. Moreover, it appears that secondary induced environmental stress can lead to the emergence of psychopathologies and increased susceptibility to viral (re)infection in infected individuals. We hypothesize that a positive feedback loop of virus-environment-reinforced systemic responses exists. It is surmised that this cycle of primary virulent activity and secondary stress-induced reactivation, may be detrimental to infected individuals by maintaining and reinforcing the host's immunocompromised state of chronic inflammation, immunological strain, and maladaptive central-nervous-system activity. We propose that this state can lead to perturbed cognitive processing and promote aversive learning, which may manifest as acute, long-term neuropsychiatric illness.
Zobrazit více v PubMed
Ptacek R, Ptackova H, Martin A, Stefano GB. Psychiatric manifestations of COVID-19 and their social significance. PubMed DOI PMC
Chenneville T, Gabbidon K, Hanson P, Holyfield C. The impact of COVID-19 on HIV treatment and research: a call to action. PubMed DOI PMC
Parasher A. COVID research: a year of scientific milestones. PubMed DOI
Wang C, Wang Z, Wang G, Lau JY, Zhang K, Li W. COVID-19 in early 2021: current status and looking forward. PubMed DOI PMC
Stefano GB, Ptacek R, Ptackova H, Martin A, Kream RM. Selective neuronal mitochondrial targeting in SARS-CoV-2 infection affects cognitive processes to induce “Brain Fog” and results in behavioral changes that favor viral survival. PubMed DOI PMC
Wang F, Kream RM, Stefano GB. Long-term respiratory and neurological sequelae of COVID-19. PubMed DOI PMC
Stefano GB, Buttiker P, Weissenberger S, Martin A, Ptacek R, Kream RM. Editorial: the pathogenesis of long-term neuropsychiatric COVID-19 and the role of microglia, mitochondria, and persistent neuroinflammation: a hypothesis. PubMed DOI PMC
Thangaraj A, Periyasamy P, Liao K, et al. HIV-1 TAT-mediated microglial activation: role of mitochondrial dysfunction and defective mitophagy. PubMed DOI PMC
Qiao H, Guo M, Shang J, et al. Herpes simplex virus type 1 infection leads to neurodevelopmental disorder-associated neuropathological changes. PubMed DOI PMC
Lotsch F, Schnyder J, Goorhuis A, Grobusch MP. Neuropsychological long-term sequelae of Ebola virus disease survivors - A systematic review. PubMed DOI
Bah AJ, James PB, Bah N, Sesay AB, Sevalie S, Kanu JS. Prevalence of anxiety, depression and post-traumatic stress disorder among Ebola survivors in northern Sierra Leone: a cross-sectional study. PubMed DOI PMC
Wallet C, De Rovere M, Van Assche J, et al. Microglial cells: the main HIV-1 reservoir in the brain. review. PubMed DOI PMC
Illanes-Alvarez F, Marquez-Ruiz D, Marquez-Coello M, Cuesta-Sancho S, Giron-Gonzalez JA. Similarities and differences between HIV and SARS-CoV-2. PubMed DOI PMC
Osborne O, Peyravian N, Nair M, Daunert S, Toborek M. The paradox of HIV blood-brain barrier penetrance and antiretroviral drug delivery deficiencies. PubMed DOI PMC
Sawada M, Suzumura A, Marunouchi T. Down regulation of CD4 expression in cultured microglia by immunosuppressants and lipopolysaccharide. PubMed DOI
Stefano GB, Bilfinger TV, Fricchione GL. The immune-neuro-link and the macrophage: postcardiotomy delirium, HIV-associated dementia and psychiatry. PubMed DOI
Meyding-Lamade U, Strank C. Herpesvirus infections of the central nervous system in immunocompromised patients. PubMed DOI PMC
Keita AK, Koundouno FR, Faye M, et al. Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks. PubMed DOI
Tavcar P, Potokar M, Kolenc M, et al. Neurotropic viruses, astrocytes, and COVID-19. PubMed DOI PMC
Yachou Y, El Idrissi A, Belapasov V, Ait Benali S. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients. PubMed DOI PMC
Xiang Q, Feng Z, Diao B, et al. SARS-CoV-2 induces lymphocytopenia by promoting inflammation and decimates secondary lymphoid organs. PubMed DOI PMC
Kumari P, Rothan HA, Natekar JP, et al. Neuroinvasion and encephalitis following intranasal inoculation of SARS-CoV-2 in K18-hACE2 mice. PubMed DOI PMC
Büttiker P, Weissenberger S, Stefano GB, Kream RM, Ptacek R. SARS-CoV-2, trait anxiety, and the microbiome. Mini review. PubMed DOI PMC
Stefano GB, Buttiker P, Kream RM. Reassessment of the blood-brain barrier: a potential target for viral entry into the immune-privileged brain. PubMed DOI PMC
Levine A, Sacktor N, Becker JT. Studying the neuropsychological sequelae of SARS-CoV-2: lessons learned from 35 years of neuroHIV research. PubMed DOI PMC
Stefano GB. Historical insight into infections and disorders associated with neurological and psychiatric sequelae similar to long COVID. PubMed DOI PMC
Mayer KA, Stockl J, Zlabinger GJ, Gualdoni GA. Hijacking the supplies: metabolism as a novel facet of virus-host interaction. PubMed DOI PMC
Kirsch-Volders M, Fenech M. Inflammatory cytokine storms severity may be fueled by interactions of micronuclei and RNA viruses such as COVID-19 virus SARS-CoV-2. A hypothesis. PubMed DOI PMC
Ollig J, Kloubert V, Taylor KM, Rink L. B cell activation and proliferation increase intracellular zinc levels. PubMed DOI PMC
Sanchez EL, Lagunoff M. Viral activation of cellular metabolism. PubMed DOI PMC
Carty M, Guy C, Bowie AG. Detection of Viral Infections by Innate Immunity. PubMed DOI
Shytaj IL, Procopio FA, Tarek M, et al. Glycolysis downregulation is a hallmark of HIV-1 latency and sensitizes infected cells to oxidative stress. PubMed DOI PMC
Duette G, Pereyra Gerber P, Rubione J, et al. Induction of HIF-1alpha by HIV-1 infection in CD4(+) T cells promotes viral replication and drives extracellular vesicle-mediated inflammation. PubMed DOI PMC
Kang S, Tang H. HIV-1 infection and glucose metabolism reprogramming of T cells: another approach toward functional cure and reservoir eradication. PubMed DOI PMC
Haroon E, Miller AH, Sanacora G. Inflammation, glutamate, and glia: a trio of trouble in mood disorders. PubMed DOI PMC
Murphy MP. How mitochondria produce reactive oxygen species. PubMed DOI PMC
Kanellopoulos AK, Mariano V, Spinazzi M, et al. Aralar sequesters GABA into hyperactive mitochondria, causing social behavior deficits. PubMed DOI
Bharadwaj S, Singh M, Kirtipal N, Kang SG. SARS-CoV-2 and glutamine: SARS-CoV-2 triggered pathogenesis via metabolic reprograming of glutamine in host cells. PubMed DOI PMC
Stefano GB, Kream RM. Mitochondrial DNA heteroplasmy as an informational reservoir dynamically linked to metabolic and immunological processes associated with COVID-19 neurological disorders. PubMed DOI PMC
Stefano GB, Kream RM. Viruses broaden the definition of life by genomic incorporation of artificial intelligence and machine learning processes. PubMed DOI PMC
Majolo F, Silva GLD, Vieira L, et al. Neuropsychiatric disorders and COVID-19: what we know so far. PubMed DOI PMC
Iadecola C, Anrather J, Kamel H. Effects of COVID-19 on the nervous system. PubMed DOI PMC
Wenzel J, Lampe J, Muller-Fielitz H, et al. The SARS-CoV-2 main protease M(pro) causes microvascular brain pathology by cleaving NEMO in brain endothelial cells. PubMed DOI PMC
Bodnar B, Patel K, Ho W, Luo JJ, Hu W. Cellular mechanisms underlying neurological/neuropsychiatric manifestations of COVID-19. PubMed DOI PMC
Hosen I, Al-Mamun F, Mamun MA. Prevalence and risk factors of the symptoms of depression, anxiety, and stress during the COVID-19 pandemic in Bangladesh: a systematic review and meta-analysis. PubMed DOI PMC
Alzahrani F, Alshahrani NZ, Abu sabah A, Zarbah A, Abu Sabah S, Mamun MA. Prevalence and factors associated with mental health problems in Saudi general population during the coronavirus disease 2019 pandemic: a systematic review and meta-analysis. PubMed DOI
Rogers JP, Chesney E, Oliver D, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. PubMed DOI PMC
Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. PubMed DOI PMC
Singer EJ, Thames AD. Neurobehavioral manifestations of human immunodeficiency virus/AIDS: diagnosis and treatment. PubMed DOI PMC
Alvarez-Carbonell D, Ye F, Ramanath N, et al. Cross-talk between microglia and neurons regulates HIV latency. PubMed DOI PMC
Celesia BM, Nigro L, Pinzone MR, et al. High prevalence of undiagnosed anxiety symptoms among HIV-positive individuals on cART: a cross-sectional study. PubMed
Smith MY, Egert J, Winkel G, Jacobson J. The impact of PTSD on pain experience in persons with HIV/AIDS. PubMed DOI
Shacham E, Morgan JC, Onen NF, Taniguchi T, Overton ET. Screening anxiety in the HIV clinic. PubMed DOI PMC
Ye J, Wen Y, Chu X, et al. Association between herpes simplex virus 1 exposure and the risk of depression in UK Biobank. PubMed DOI PMC
van Heugten-van der Kloet D, van Heugten T. The classification of psychiatric disorders according to DSM-5 deserves an internationally standardized psychological test battery on symptom level. PubMed DOI PMC
Mamun MA. Exploring factors in fear of COVID-19 and its GIS-based nationwide distribution: the case of Bangladesh. PubMed DOI PMC
Al Mamun F, Hosen I, Misti JM, Kaggwa MM, Mamun MA. Mental disorders of bangladeshi students during the COVID-19 pandemic: a systematic review. PubMed DOI PMC
Taylor MA, Vaidya NA. Psychopathology in neuropsychiatry: DSM and beyond. PubMed DOI
Saladino V, Algeri D, Auriemma V. The psychological and social impact of covid-19: new perspectives of well-being. PubMed DOI PMC
Tolentino JC, Schmidt SL. DSM-5 criteria and depression severity: implications for clinical practice. original research. PubMed DOI PMC
Segerstrom SC, Miller GE. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. PubMed DOI PMC
Buttiker P, Weissenberger S, Ptacek R, Stefano GB. Interoception, trait anxiety, and the gut microbiome: a cognitive and physiological model. PubMed DOI PMC
Srivastava KK, Kumar R. Stress, oxidative injury and disease. PubMed DOI PMC
Schiavone S, Jaquet V, Trabace L, Krause KH. Severe life stress and oxidative stress in the brain: from animal models to human pathology. PubMed DOI PMC
Simioni C, Zauli G, Martelli AM, et al. Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging. PubMed DOI PMC
Erickson MA, Rhea EM, Knopp RC, Banks WA. Interactions of SARS-CoV-2 with the blood-brain barrier. PubMed DOI PMC
Rhea EM, Logsdon AF, Hansen KM, et al. The S1 protein of SARS-CoV-2 crosses the blood-brain barrier in mice. PubMed DOI PMC
Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG. Into the eye of the cytokine storm. PubMed DOI PMC
Cox MA, Kahan SM, Zajac AJ. Anti-viral CD8 T cells and the cytokines that they love. PubMed DOI PMC
Stefano GB, Pilonis N, Ptacek R, Raboch J, Vnukova M, Kream RM. Gut, microbiome, and brain regulatory axis: relevance to neurodegenerative and psychiatric disorders. PubMed DOI PMC
Putra RD, Lyrawati D. Interactions between bacteriophages and eukaryotic cells. PubMed DOI PMC
Van Belleghem JD, Dabrowska K, Vaneechoutte M, Barr JJ, Bollyky PL. Interactions between bacteriophage, bacteria, and the mammalian immune system. PubMed DOI PMC
Ma Q, Xing C, Long W, Wang HY, Liu Q, Wang RF. Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis. PubMed DOI PMC
Garry RF. Ebola virus can lie low and reactivate after years in human survivors. PubMed DOI